Camryn Lieb, ScM

Senior Scientist, Pharmacoepidemiology & Safety
Genesis Research Group

Poster(s):

• (A-229) A,B,Cs of ADCs (Antibody–Drug Conjugates) Post-Marketing Pharmacoepidemiology Planning
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-026) Identifying opportunities and challenges in the use of real-world data to support the ongoing benefit-risk evaluation of new treatments for Alzheimer’s Disease
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLC-039) Rare Findings: Characterizing External Control Arm Studies Assessed by FDA for Drugs and Biologics in Rare Disease
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET